查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662686

福斯高林市场预测至 2030 年：按来源、形式、浓度、应用、最终用户和地区进行的全球分析

Forskolin Market Forecasts to 2030 - Global Analysis by Source (Natural and Synthetic), Form (Powder, Capsules/Tablets, Liquid and Raw Extract), Concentration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球福斯高林市场价值为 5.832 亿美元，预计到 2030 年将达到 10.2205 亿美元，预测期内的复合年增长率为 9.8%。

福斯可林是一种天然化合物，来自薄荷家族的毛喉鞘蕊花（Coleus forskohlii）植物的根。它传统上在阿育吠陀医学中用于多种健康益处。福斯可林以其能够提高体内环磷酸腺苷 (cAMP) 的水平而闻名，环磷酸腺苷是一种在调节许多生理过程方面发挥作用的分子，包括脂肪分解、心臟功能和免疫反应。福斯可林通常作为减肥补充剂出售，儘管支持其有效性的研究有限。人们也正在研究它在治疗心臟病、气喘和青光眼的潜在用途。

据悉，美国是北美地区福斯高林的主要市场，占90%以上的市场占有率。

对天然补充品的需求不断增加

对天然补充剂的需求不断增长，对福斯可林市场产生了重大影响。福斯可林衍生毛喉鞘蕊花植物，因其天然的体重管理、抗发炎和心臟健康功效而越来越受到追捧。随着消费者青睐植物性和有机产品，福斯可林在膳食补充剂、减重产品和健康解决方案中的受欢迎程度持续成长。对天然健康解决方案的追求以及对福斯高林益处的认识不断提高，推动了零售和健康领域的需求，从而促进了市场扩张。

产品成本高

产品成本高是福斯高林产业的一个主要障碍，限制了消费者的取得并减少了需求。保持产品价格低廉并维持利润率对于製造商来说是一个挑战。此外，高成本带来的价格战可能会赶走规模较小的竞争对手。即使福斯可林产品在健康和保健行业中越来越受欢迎，这也可能限制其潜在影响力，尤其是在价格敏感的国家，并阻碍整体市场的成长。

健身与健康领域热门

健身和健康趋势日益流行，极大地推动了福斯可林市场的发展，因为人们越来越认识到它对减重、减脂和增强肌肉质量的潜在益处。随着消费者的健康意识不断增强，对福斯可林等天然补充品的需求正在激增。此外，线上健康社群、健身影响者和健康计画的兴起进一步推动了人们对基于福斯可林的产品的认识和采用。预计这一趋势将持续下去，推动健身和健康领域的市场成长。

副作用和安全问题

由于使用过程中产生的副作用和安全问题，福斯可林市场面临障碍。低血压、心率加快和消化器官系统问题等潜在副作用可能会阻碍消费者的采用。此外，缺乏足够的法律规范和关于其有效性和安全性的不一致的临床证据可能会引起消费者和医疗专业人士的怀疑。这些因素导致市场成长缓慢，各地区接受度谨慎。

COVID-19 的影响

COVID-19 疫情对亚太地区福斯高林市场产生了负面影响，扰乱了供应链，并因经济不确定性限制了消费者支出。然而，在疫情期间，人们对健康和免疫支持的关注度增加，导致对包括福斯可林在内的天然补充剂的需求增加。网路分销管道的日益重要以及消费者对健康和体重管理兴趣的增加促进了市场的逐步復苏。

营养补充品市场预计将在预测期内实现最大幅度成长

由于消费者对自然有效的体重管理、燃脂和整体健康解决方案的需求不断增长，预计膳食补充剂领域将在预测期内占据最大的市场占有率。福斯可林在补充剂中很受欢迎，尤其是它具有促进新陈代谢、促进脂肪减少和支持心血管健康的潜力，促进了市场的成长。随着消费者越来越多地寻求植物性和整体性的合成产品替代品，膳食补充剂行业正在进一步扩大，加速了对各种健康相关配方中福斯可林的需求。

预测期内，青光眼领域预计将以最高复合年增长率成长

在预测期内，由于福斯可林的潜在治疗益处，预计青光眼领域将呈现最高的成长率。研究表明，福斯可林有助于降低眼压，这是青光眼管理的重要因素。因此，福斯可林作为青光眼的天然替代疗法或补充治疗方法越来越受到关注。青光眼的发生率不断上升，尤其是在老龄人口中，以及人们对草药治疗眼部健康的兴趣日益浓厚，推动了市场对以福斯可林为基础的解决方案的需求，从而促进了其在医疗保健领域的扩张。

比最大的地区

在预测期内，由于膳食补充剂（尤其是减脂和增肌膳食补充剂）的日益普及，预计北美地区将占据最大的市场占有率，从而支持对基于福斯高林的产品的需求。注重健康的消费者越来越多地提倡在保健补充剂中使用福斯可林，并选择植物性的天然补充剂。此外，人们越来越意识到福斯可林在改善心臟健康和控制肥胖方面的潜在益处，这进一步推动了北美市场的成长，特别是在饮食和健身补充剂领域。

复合年增长率最高的地区

在预测期内，由于人们对健康和保健趋势的认识不断增强，预计亚太地区将呈现最高的复合年增长率。可支配收入的增加和更健康的生活方式的转变进一步促进了市场的成长。在印度和中国等国家的传统医疗实践的支持下，草药补充剂行业的扩张也刺激了对以福斯可林为基础的补充剂的需求。此外，福斯可林因其对心血管健康和减肥有潜在益处而广受欢迎，这也推动了其在该地区的市场渗透。

提供免费客製化

本报告的每位客户都将获得以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球福斯高林市场依来源划分

  • 介绍
  • 自然的
  • 合成

6. 全球福斯高林市场按形式

  • 介绍
  • 粉末
  • 胶囊/锭剂
  • 液体
  • 原料萃取物

7. 全球福斯高林市场实力

  • 介绍
  • 低浓度（10%）
  • 中等浓度（20% 至 40%）
  • 高浓度（95%）

8. 全球福斯高林市场（按应用）

  • 介绍
  • 过敏治疗
  • 体重管理
  • 呼吸问题
  • 心血管疾病
  • 青光眼
  • 甲状腺机能低下症
  • 干癣
  • 其他的

第 9 章 全球福斯高林市场（按最终用户）

  • 介绍
  • 营养补充品
  • 药品
  • 营养补充品
  • 食品加工
  • 化妆品
  • 其他的

第 10 章 全球福斯高林市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Acumen Pharmaceuticals, Inc.
  • Alchem International Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Biosynthesis Inc.
  • Cayman Chemical Company
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • ChromaDex, Inc.
  • Hunan Nutramax Inc.
  • Indena SpA
  • Indofine Chemical Company, Inc.
  • LGM Pharma
  • LKT Laboratories, Inc.
  • MediHerb Pty Ltd.
  • Nutra Green BIoTechnology Co., Ltd.
  • Sabinsa Corporation
  • Shaanxi Green Bio-Engineering Co., Ltd.
  • Sigma-Aldrich Corporation
  • TCI America
  • Xi'an Natural Field Bio-Technique Co., Ltd.
Product Code: SMRC28547

According to Stratistics MRC, the Global Forskolin Market is accounted for $583.2 million in 2024 and is expected to reach $1022.05 million by 2030 growing at a CAGR of 9.8% during the forecast period. Forskolin is a natural compound derived from the root of the Coleus forskohlii plant, which belongs to the mint family. It has been traditionally used in Ayurvedic medicine for various health benefits. Forskolin is known for its ability to increase levels of cyclic AMP (cAMP) in the body, a molecule that plays a role in regulating many physiological processes, including fat breakdown, heart function, and immune response. Forskolin is commonly marketed as a weight loss supplement, though research supporting its effectiveness for this purpose is limited. It is also being investigated for potential uses in managing heart disease, asthma, and glaucoma.

According to reports, the United States is the dominant market for forskolin in North America, accounting for over 90% of the market share.

Market Dynamics:

Driver:

Increasing Demand for Natural Supplements

The rising demand for natural supplements is significantly impacting the Forskolin market. Forskolin, derived from the Coleus forskohlii plant, is increasingly sought after due to its natural weight management, anti-inflammatory, and heart health benefits. As consumers prefer plant-based and organic products, Forskolin's popularity in dietary supplements, weight loss products, and wellness solutions continues to grow. The trend towards natural health solutions, along with rising awareness of the benefits of Forskolin, is fostering market expansion, driving demand in both the retail and wellness sectors.

Restraint:

High Product Costs

High product costs are a key barrier in the Forskolin industry, limiting consumer access and reducing demand. Maintaining profit margins while keeping product prices low may be challenging for manufacturers. Furthermore, price rivalry brought on by high expenses may drive out smaller competitors. Even if forskolin products are becoming more and more well-liked in the health and wellness industry, this might restrict their potential reach and impede overall market growth, particularly in price-sensitive countries.

Opportunity:

Popularity in Fitness and Wellness

The growing popularity of fitness and wellness trends is significantly driving the Forskolin market, as it is increasingly recognized for its potential benefits in weight loss, fat reduction, and enhancing muscle mass. As consumers become more health-conscious, the demand for natural supplements like Forskolin has surged. Additionally, the rise of online health communities, fitness influencers, and wellness programs further boosts the awareness and adoption of Forskolin-based products. This trend is expected to continue, fueling market growth in the fitness and wellness sector.

Threat:

Side Effects and Safety Concerns

The Forskolin market faces hindrance due to side effects and safety concerns associated with its use. Potential side effects such as low blood pressure, increased heart rate, and digestive issues can deter consumer adoption. Additionally, the lack of sufficient regulatory oversight and inconsistent clinical evidence regarding its effectiveness and safety may raise doubts among consumers and healthcare professionals. These factors contribute to slower market growth and cautious acceptance in various regions.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Forskolin market in Asia-Pacific, disrupting supply chains and limiting consumer spending due to economic uncertainty. However, the increased focus on health and immune support during the pandemic led to a rise in demand for natural supplements, including Forskolin. Online sales channels gained prominence, contributing to the market's gradual recovery as consumer interest in wellness and weight management grew.

The dietary supplements segment is expected to be the largest during the forecast period

The dietary supplements segment is expected to account for the largest market share during the forecast period, due to rising consumer demand for natural and effective weight management, fat burning, and overall health solutions. Forskolin's popularity in supplements, particularly for its potential to enhance metabolism, promote fat loss, and support cardiovascular health, is contributing to market growth. As consumers increasingly seek plant-based and holistic alternatives to synthetic products, the dietary supplement sector is expanding, further accelerating the demand for Forskolin in various health-related formulations.

The glaucoma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the glaucoma segment is predicted to witness the highest growth rate due to Forskolin's potential therapeutic benefits. Research suggests that Forskolin can help reduce intraocular pressure, a key factor in glaucoma management. As a result, Forskolin is gaining attention as a natural alternative or complementary treatment for glaucoma. The growing prevalence of glaucoma, particularly in aging populations, alongside increasing interest in herbal remedies for eye health, is driving the demand for Forskolin-based solutions in the market, contributing to its expansion in the healthcare sector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to increasing popularity of dietary supplements, especially for fat loss and muscle building, supports demand for Forskolin-based products. Health-conscious consumers are increasingly opting for plant-based, natural alternatives, propelling Forskolin's use in wellness supplements. Additionally, the expanding awareness of Forskolin's potential benefits in improving heart health and managing obesity further drives its market growth in North America, particularly in the dietary and fitness supplement sectors.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to growing awareness of health and wellness trends. Rising disposable incomes and a shift toward healthier lifestyles further contribute to the market's growth. The expanding herbal supplement industry, supported by traditional medicine practices in countries like India and China, also fuels the demand for Forskolin-based supplements. Additionally, the popularity of Forskolin for its potential benefits in cardiovascular health and fat loss drives its market penetration in the region.

Key players in the market

Some of the key players in Forskolin market include Acumen Pharmaceuticals, Inc., Alchem International Ltd., Bio-gen Extracts Pvt. Ltd., Biosynthesis Inc., Cayman Chemical Company, Changsha Staherb Natural Ingredients Co., Ltd., ChromaDex, Inc., Hunan Nutramax Inc., Indena S.p.A., Indofine Chemical Company, Inc., LGM Pharma, LKT Laboratories, Inc, MediHerb Pty Ltd., Nutra Green Biotechnology Co., Ltd., Sabinsa Corporation, Shaanxi Green Bio-Engineering Co., Ltd., Sigma-Aldrich Corporation, TCI America and Xi'an Natural Field Bio-Technique Co., Ltd.

Key Developments:

In September 2024, Acumen Pharmaceuticals, Inc. announced that it has extended its collaboration with Lonza to enable the potential future commercial launch of sabirnetug (ACU193).

In September 2024, Cayman Chemical and Certest Pharma announced a new partnership to make Certest proprietary ionizable lipids available for LNP research through Cayman's online catalog and global network of distributors.

In November 2023, Acumen Pharmaceuticals, Inc. announced non-exclusive collaboration and license agreement with Halozyme Therapeutics Inc. The collaboration will provide Acumen access to Halozyme's ENHANZE drug delivery technology, for the development of a subcutaneous formulation of ACU193, the first clinical-stage ABO-targeting antibody.

Sources Covered:

  • Natural
  • Synthetic

Forms Covered:

  • Powder
  • Capsules/Tablets
  • Liquid
  • Raw Extract

Concentrations Covered:

  • Low Concentration (10%)
  • Medium Concentration (20% to 40%)
  • High Concentration (95%)

Applications Covered:

  • Allergy Treatment
  • Weight Management
  • Respiratory Problems
  • Cardiovascular Disorders
  • Glaucoma
  • Hypothyroidism
  • Psoriasis
  • Other Applications

End Users Covered:

  • Nutraceuticals
  • Pharmaceutical
  • Dietary Supplements
  • Food Processing
  • Cosmetics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Forskolin Market, By Source

  • 5.1 Introduction
  • 5.2 Natural
  • 5.3 Synthetic

6 Global Forskolin Market, By Form

  • 6.1 Introduction
  • 6.2 Powder
  • 6.3 Capsules/Tablets
  • 6.4 Liquid
  • 6.5 Raw Extract

7 Global Forskolin Market, By Concentration

  • 7.1 Introduction
  • 7.2 Low Concentration (10%)
  • 7.3 Medium Concentration (20% to 40%)
  • 7.4 High Concentration (95%)

8 Global Forskolin Market, By Application

  • 8.1 Introduction
  • 8.2 Allergy Treatment
  • 8.3 Weight Management
  • 8.4 Respiratory Problems
  • 8.5 Cardiovascular Disorders
  • 8.6 Glaucoma
  • 8.7 Hypothyroidism
  • 8.8 Psoriasis
  • 8.9 Other Applications

9 Global Forskolin Market, By End User

  • 9.1 Introduction
  • 9.2 Nutraceuticals
  • 9.3 Pharmaceutical
  • 9.4 Dietary Supplements
  • 9.5 Food Processing
  • 9.6 Cosmetics
  • 9.7 Other End Users

10 Global Forskolin Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Acumen Pharmaceuticals, Inc.
  • 12.2 Alchem International Ltd.
  • 12.3 Bio-gen Extracts Pvt. Ltd.
  • 12.4 Biosynthesis Inc.
  • 12.5 Cayman Chemical Company
  • 12.6 Changsha Staherb Natural Ingredients Co., Ltd.
  • 12.7 ChromaDex, Inc.
  • 12.8 Hunan Nutramax Inc.
  • 12.9 Indena S.p.A.
  • 12.10 Indofine Chemical Company, Inc.
  • 12.11 LGM Pharma
  • 12.12 LKT Laboratories, Inc.
  • 12.13 MediHerb Pty Ltd.
  • 12.14 Nutra Green Biotechnology Co., Ltd.
  • 12.15 Sabinsa Corporation
  • 12.16 Shaanxi Green Bio-Engineering Co., Ltd.
  • 12.17 Sigma-Aldrich Corporation
  • 12.18 TCI America
  • 12.19 Xi'an Natural Field Bio-Technique Co., Ltd.

List of Tables

  • Table 1 Global Forskolin Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Forskolin Market Outlook, By Source (2022-2030) ($MN)
  • Table 3 Global Forskolin Market Outlook, By Natural (2022-2030) ($MN)
  • Table 4 Global Forskolin Market Outlook, By Synthetic (2022-2030) ($MN)
  • Table 5 Global Forskolin Market Outlook, By Form (2022-2030) ($MN)
  • Table 6 Global Forskolin Market Outlook, By Powder (2022-2030) ($MN)
  • Table 7 Global Forskolin Market Outlook, By Capsules/Tablets (2022-2030) ($MN)
  • Table 8 Global Forskolin Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 9 Global Forskolin Market Outlook, By Raw Extract (2022-2030) ($MN)
  • Table 10 Global Forskolin Market Outlook, By Concentration (2022-2030) ($MN)
  • Table 11 Global Forskolin Market Outlook, By Low Concentration (10%) (2022-2030) ($MN)
  • Table 12 Global Forskolin Market Outlook, By Medium Concentration (20% to 40%) (2022-2030) ($MN)
  • Table 13 Global Forskolin Market Outlook, By High Concentration (95%) (2022-2030) ($MN)
  • Table 14 Global Forskolin Market Outlook, By Application (2022-2030) ($MN)
  • Table 15 Global Forskolin Market Outlook, By Allergy Treatment (2022-2030) ($MN)
  • Table 16 Global Forskolin Market Outlook, By Weight Management (2022-2030) ($MN)
  • Table 17 Global Forskolin Market Outlook, By Respiratory Problems (2022-2030) ($MN)
  • Table 18 Global Forskolin Market Outlook, By Cardiovascular Disorders (2022-2030) ($MN)
  • Table 19 Global Forskolin Market Outlook, By Glaucoma (2022-2030) ($MN)
  • Table 20 Global Forskolin Market Outlook, By Hypothyroidism (2022-2030) ($MN)
  • Table 21 Global Forskolin Market Outlook, By Psoriasis (2022-2030) ($MN)
  • Table 22 Global Forskolin Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Forskolin Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Forskolin Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 25 Global Forskolin Market Outlook, By Pharmaceutical (2022-2030) ($MN)
  • Table 26 Global Forskolin Market Outlook, By Dietary Supplements (2022-2030) ($MN)
  • Table 27 Global Forskolin Market Outlook, By Food Processing (2022-2030) ($MN)
  • Table 28 Global Forskolin Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 29 Global Forskolin Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.